Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. We imagine a world where cancer is a curable disease.
At Replimune, we live by our values:
United: We Collaborate for a Common Goal.
Audacious: We Are Bold and Innovative.
Dedicated: We Give Our Full Commitment.
Candid: We Are Honest With Each Other.
People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do which could impact the lives of patients.
Join us, as we reshape the future.
Job Summary:
This Senior Manager, Contracts will report to the Executive Director, Corporate Counsel and provide legal support to the Legal Department and various related business teams in a fast-paced, fast-growth biotechnology company. This position will closely collaborate with members of the Legal team, and other cross-functional teams, to provide legal/paralegal services primarily focusing on managing HCP engagements.
This position is based in our Woburn office and welcomes hybrid work! Local candidates are expected to be on-site 2 days per week.
Key responsibilities:
This is a dynamic and important role in the legal function of a high-growth biotech company as we rapidly progress the company toward a commercial organization. The successful candidate will provide a wide variety of legal support, primarily focused on supporting various functions with healthcare professional (HCP) engagements and related matters.
Healthcare Professional Contracting Support
Vendor Contracting Support
General Legal and Compliance Support
Other responsibilities:
Education:
Required Experience:
About Replimune
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.
We are an Equal Opportunity Employer.
#LI-Hybrid
Software Powered by iCIMS
www.icims.com